Literature DB >> 14494659

The release of cholesterol esters from serum lipoproteins by extracts of certain group A streptococci.

R ROWEN.   

Abstract

A chemical explanation has been provided for the production of opalescence in human and animal sera by extracts of certain Group A streptococci. Opalescence results from the selective liberation of specific lipids from alpha(1)-serum lipoprotein. The released lipids have been quantitatively separated through the relatively simple technique of ultracentrifugal flotation, and subsequently analyzed by chemical and chromatographic means. Esterified cholesterol constitutes by far the major low density reaction product, accounting for 85 to 90 per cent of the total lipid released. A small amount of phospholipid (apparently limited to lecithin) was the only other lipid consistently found in low density product fractions. Comparative kinetics of opalescence development and cholesterol release under varying conditions of pH, extract concentration, and temperature reveal that the two effects do not run exactly parallel but are, nevertheless, probably closely related manifestations of a specific enzymic degradation of serum lipoprotein. It has been suggested that enzymic action may occur at a site within the lipoprotein remote from the cholesterol esters themselves. Although the over-all reaction appears to be mediated by an enzyme present in many Group A streptococci, it is uncertain whether this enzyme acts directly on lipoprotein or acts by causing the activation of a serum enzyme which in turn attacks the lipoprotein.

Entities:  

Keywords:  CHOLESTEROL/metabolism; LIPOPROTEINS/blood; STREPTOCOCCUS/extracts

Mesh:

Substances:

Year:  1961        PMID: 14494659      PMCID: PMC2180383          DOI: 10.1084/jem.114.5.807

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Lipid composition of human serum lipoprotein fraction with density greater than I. 210.

Authors:  G B PHILLIPS
Journal:  Proc Soc Exp Biol Med       Date:  1959-01

2.  Direct chromatography of serum lipids without solvent extraction.

Authors:  G V MARINETTI; E STOTZ
Journal:  Biochim Biophys Acta       Date:  1960-01-29

3.  [Lipoprotein complexes of horse serum and their importance in immunological phenomena. I. Normal sera].

Authors:  S MONDINI
Journal:  Boll Ist Sieroter Milan       Date:  1957 Sep-Oct

4.  The toxic action of preparations containing the oxygen-labile hemolysin of Streptococcus pyogenes. V. Mechanism of refractoriness to the lethal effect of the toxin.

Authors:  R ROWEN; A W BERNHEIMER
Journal:  J Immunol       Date:  1956-07       Impact factor: 5.422

5.  Human serum lipoproteins. I. Chemical composition of four fractions.

Authors:  J H BRAGDON; R J HAVEL; E BOYLE
Journal:  J Lab Clin Med       Date:  1956-07

6.  A new procedure for staining lipoproteins in ionographic separations.

Authors:  H J McDONALD; E W BERMES
Journal:  Biochim Biophys Acta       Date:  1955-06

7.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

8.  Role of serum albumin in lipemia clearing reaction.

Authors:  R S GORDON; E BOYLE; R K BROWN; A CHERKES; C B ANFINSEN
Journal:  Proc Soc Exp Biol Med       Date:  1953-10

9.  A revision of the Schoenheimer-Sperry method for cholesterol determination.

Authors:  W M SPERRY; M WEBB
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

10.  Studies on a lipoproteinase of group A streptococci.

Authors:  E KRUMWIEDE
Journal:  J Exp Med       Date:  1954-12-01       Impact factor: 14.307

View more
  7 in total

1.  The serum opacity reaction of Streptococcus pyogenes: general properties of the streptococcal factor and of the reaction in aged serum.

Authors:  M J Hill; L W Wannamaker
Journal:  J Hyg (Lond)       Date:  1968-03

2.  DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding repeat domain.

Authors:  J V Rakonjac; J C Robbins; V A Fischetti
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

3.  Microtechnique for serum opacity factor characterization of group A streptococci adaptable to the use of human sera.

Authors:  D R Johnson; E L Kaplan
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

Review 4.  The structure and function of serum opacity factor: a unique streptococcal virulence determinant that targets high-density lipoproteins.

Authors:  Harry S Courtney; Henry J Pownall
Journal:  J Biomed Biotechnol       Date:  2010-07-08

5.  Comparison of methods for obtaining serum opacity factor from group A streptococci.

Authors:  C D Rehder; D R Johnson; E L Kaplan
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

6.  The serum opacity reaction of Streptococcus pyogenes. The demonstration of multiple, strain-specific lipoproteinase antigens.

Authors:  F H Top; L W Wannamaker
Journal:  J Exp Med       Date:  1968-05-01       Impact factor: 14.307

7.  OXYGEN-STABLE HEMOLYSINS OF GROUP A STREPTOCCI. IV. STUDIES ON THE MECHANISM OF LYSIS BY CELL-BOUND HEMOLYSIN OF RED BLOOD CELLS AND EHRLICH ASCITES TUMOR CELLS.

Authors:  I GINSBURG; T N HARRIS
Journal:  J Exp Med       Date:  1965-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.